Verrica Pharmaceuticals Inc.
VRCA$27M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaWEST CHESTER71 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
May 13, 2026
25dMarket Overview
Stock performance and key metrics
VRCA News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Part 1: VP-315 3 Day Dosing/Week | Phase 2 | Basal Cell Carcinoma | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply